Search

Sandoz Group AG

Abierto

35.84 -0.17

Resumen

Variación precio

24h

Actual

Mínimo

35.5

Máximo

36.49

Métricas clave

By Trading Economics

Ingresos

150M

Ventas

5.1B

Rentabilidad por dividendo

1.62

Margen de beneficios

2.963

Empleados

22,049

EBITDA

541M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+19.22% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.62%

2.39%

Próximas Ganancias

30 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

16B

Apertura anterior

36.01

Cierre anterior

35.84

Sandoz Group AG Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 dic 2024, 07:45 UTC

Charlas de Mercado

Sandoz's U.S. Settlement to Cost 1.1 Swiss Francs a Share -- Market Talk

17 dic 2024, 07:34 UTC

Charlas de Mercado

Sandoz's U.S. Settlement Shows Commitment Move Forward -- Market Talk

10 dic 2024, 07:05 UTC

Charlas de Mercado

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

Sandoz Group AG previsión

Precio Objetivo

By TipRanks

19.22% repunte

Estimación a 12 Meses

Media 43.407 CHF  19.22%

Máximo 46.5 CHF

Mínimo 38 CHF

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Sandoz Group AG Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

9 ratings

5

Comprar

4

Mantener

0

Vender

Finanzas

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

EBITDA

Beneficio operativo

$

Acerca de Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.